{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:15:08Z","timestamp":1783437308045,"version":"3.54.6"},"reference-count":67,"publisher":"The Endocrine Society","issue":"7","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014593","name":"Neurocrine Biosciences, Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Context: Classic congenital adrenal hyperplasia (CAH) is a rare genetic condition characterized by impaired cortisol and aldosterone synthesis. Historical management required glucocorticoid (GC) therapy to replace cortisol and, often, to suppress excess ACTH and adrenal androgens. However, supraphysiologic GC doses can lead to substantial complications. Objective: This study aimed to characterize the clinical burden associated with CAH and quantify the degree to which CAH- and\/or GC-related complications manifest. Methods: Retrospective cohort analyses were conducted using administrative claims data from MarketScan\u00ae Research Databases (1\/1\/2020-12\/31\/2022) to quantify the burden of CAH- and\/or GC-related complications among insured patients with CAH in the United States compared with a matched cohort. Results: A total of 719 patients with CAH receiving GC therapy were matched 1:5 with 3595 individuals based on age, sex, payer, region, and enrollment duration. Patients with CAH had significantly higher rates of predominantly GC-related complications, including cardiovascular\/circulatory diseases, type 2 diabetes, hypertension, hyperglycemia, metabolic complications, obesity, and osteoporosis (all P &amp;lt; .05). Patients with CAH demonstrated significantly higher rates and risks of nearly all CAH-related complications compared with matched controls (P &amp;lt; .05). Rates and risks of nearly all complications categorized as both CAH- and GC-related were significantly higher among patients with CAH (P &amp;lt; .05). Rates were consistently higher in adults than pediatric patients, underscoring the progressive and cumulative nature of CAH- and GC-related morbidity. Conclusion: Individuals with CAH experience higher rates and risks of CAH- and\/or GC-related complications, highlighting the considerable burden associated with CAH and supraphysiologic GC treatment. Higher complication rates in adults emphasize the need for early and effective management of CAH. Novel non-GC therapies may enable GC dose reduction while maintaining androgen control, potentially mitigating these complications.<\/jats:p>","DOI":"10.1210\/jendso\/bvag112","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:25:35Z","timestamp":1778585135000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical burden of classic congenital adrenal hyperplasia and glucocorticoid-related complications: a claims analysis"],"prefix":"10.1210","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-7552-5038","authenticated-orcid":false,"given":"Hyunwoo","family":"Kim","sequence":"first","affiliation":[{"name":"Neurocrine Biosciences, Inc. , San Diego, CA 92130 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian H","family":"Lin","sequence":"additional","affiliation":[{"name":"Neurocrine Biosciences, Inc. , San Diego, CA 92130 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron S","family":"Newfield","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Endocrinology, Rady Children\u2019s Hospital San Diego , San Diego, CA 92123 ,","place":["USA"]},{"name":"Department of Pediatric Endocrinology, University of California San Diego , San Diego, CA 92123 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4890-0262","authenticated-orcid":false,"given":"Andrew","family":"Dauber","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Children\u2019s National Hospital , Washington, DC 20010 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Luo","sequence":"additional","affiliation":[{"name":"Neurocrine Biosciences, Inc. , San Diego, CA 92130 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Cicero","sequence":"additional","affiliation":[{"name":"Neurocrine Biosciences, Inc. , San Diego, CA 92130 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Li","sequence":"additional","affiliation":[{"name":"Trinity Life Sciences , Waltham, MA 02451 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Zhao","sequence":"additional","affiliation":[{"name":"Neurocrine Biosciences, Inc. , San Diego, CA 92130 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry Kim","family":"Cheng","sequence":"additional","affiliation":[{"name":"Neurocrine Biosciences, Inc. , San Diego, CA 92130 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"issue":"11","key":"2026070710263881300_bvag112-B1","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline","volume":"103","author":"Speiser","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"13","key":"2026070710263881300_bvag112-B2","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJMra1909786","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"383","author":"Merke","year":"2020","journal-title":"N Engl J Med"},{"key":"2026070710263881300_bvag112-B3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jsbmb.2015.05.013","article-title":"The next 150 years of congenital adrenal hyperplasia","volume":"153","author":"Turcu","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"10108","key":"2026070710263881300_bvag112-B4","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/S0140-6736(17)31431-9","article-title":"Congenital adrenal hyperplasia","volume":"390","author":"El-Maouche","year":"2017","journal-title":"Lancet"},{"issue":"6","key":"2026070710263881300_bvag112-B5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41574-022-00655-w","article-title":"Management challenges and therapeutic advances in congenital adrenal hyperplasia","volume":"18","author":"Mallappa","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2026070710263881300_bvag112-B6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1210\/endrev\/bnab016","article-title":"Congenital adrenal hyperplasia-current insights in pathophysiology, diagnostics, and management","volume":"43","author":"Claahsen-van der Grinten","year":"2022","journal-title":"Endocr Rev"},{"issue":"4","key":"2026070710263881300_bvag112-B7","first-page":"161","article-title":"Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency. Results of a multicenter study","volume":"55","author":"Hargitai","year":"2001","journal-title":"Horm Res"},{"issue":"2-03","key":"2026070710263881300_bvag112-B8","first-page":"171","article-title":"Review of health problems in adult patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"127","author":"Reisch","year":"2019","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"3","key":"2026070710263881300_bvag112-B9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/MED.0000000000000256","article-title":"Novel treatment strategies in congenital adrenal hyperplasia","volume":"23","author":"Turcu","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"12","key":"2026070710263881300_bvag112-B10","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1515\/JPEM.2008.21.12.1155","article-title":"Bone mineral density in girls with classical congenital adrenal hyperplasia due to CYP21 deficiency","volume":"21","author":"Elnecave","year":"2008","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"3","key":"2026070710263881300_bvag112-B11","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1210\/jc.2005-0745","article-title":"Long-term corticosteroid replacement and bone mineral density in adult women with classical congenital adrenal hyperplasia","volume":"91","author":"King","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026070710263881300_bvag112-B12","doi-asserted-by":"crossref","first-page":"e475","DOI":"10.1210\/clinem\/dgab712","article-title":"Increased prevalence of fractures in congenital adrenal hyperplasia: a Swedish population-based national cohort study","volume":"107","author":"Falhammar","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070710263881300_bvag112-B13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3389\/fendo.2020.00493","article-title":"Bone mineral density in adults with congenital adrenal hyperplasia: a systematic review and meta-analysis","volume":"11","author":"Rangaswamaiah","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"2026070710263881300_bvag112-B14","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1210\/jc.2006-2109","article-title":"Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty","volume":"92","author":"Bonfig","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026070710263881300_bvag112-B15","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0889-8529(05)70348-0","article-title":"Growth suppression by glucocorticoid therapy","volume":"25","author":"Allen","year":"1996","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"4","key":"2026070710263881300_bvag112-B16","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/cen.13086","article-title":"Hypertension in children with congenital adrenal hyperplasia","volume":"85","author":"Maccabee-Ryaboy","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2026070710263881300_bvag112-B17","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/cen.13313","article-title":"Obesity in children with congenital adrenal hyperplasia in the Minnesota cohort: importance of adjusting body mass index for height-age","volume":"86","author":"Sarafoglou","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2026070710263881300_bvag112-B18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1530\/EJE-10-0877","article-title":"Cardiovascular risk, metabolic profile, and body composition in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"164","author":"Falhammar","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"2026070710263881300_bvag112-B19","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1210\/JC.2015-2093","article-title":"Increased cardiovascular and metabolic morbidity in patients with 21-hydroxylase deficiency: a Swedish population-based national cohort study","volume":"100","author":"Falhammar","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026070710263881300_bvag112-B20","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1210\/jc.2010-0917","article-title":"Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients","volume":"95","author":"Arlt","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026070710263881300_bvag112-B21","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1161\/01.HYP.37.3.856","article-title":"Adverse cardiac effects of salt with fludrocortisone in hypertension","volume":"37","author":"Lim","year":"2001","journal-title":"Hypertension"},{"issue":"8","key":"2026070710263881300_bvag112-B22","doi-asserted-by":"crossref","first-page":"e2562","DOI":"10.1210\/clinem\/dgae831","article-title":"Prevalence of psychiatric comorbidities in females with classic congenital adrenal hyperplasia","volume":"110","author":"Khorashad","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070710263881300_bvag112-B23","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jad.2018.11.052","article-title":"Prospective associations of androgens and sex hormone-binding globulin with 12-month, lifetime and incident anxiety and depressive disorders in men and women from the general population","volume":"245","author":"Asselmann","year":"2019","journal-title":"J Affect Disord"},{"key":"2026070710263881300_bvag112-B24","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.2147\/JAA.S375005","article-title":"Long-term use of maintenance systemic corticosteroids is associated with multiple adverse conditions in a large, real-world cohort of US adults with severe asthma","volume":"15","author":"Lugogo","year":"2022","journal-title":"J Asthma Allergy"},{"issue":"4","key":"2026070710263881300_bvag112-B25","doi-asserted-by":"crossref","first-page":"e1009","DOI":"10.1210\/clinem\/dgae362","article-title":"Multicenter analysis of cardiometabolic-related diagnoses in youth with congenital adrenal hyperplasia: a PEDSnet study","volume":"110","author":"Chen","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070710263881300_bvag112-B26","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1129584","article-title":"Depressive and anxiety disorders and antidepressant prescriptions among insured children and young adults with congenital adrenal hyperplasia in the United States","volume":"14","author":"Harasymiw","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2026070710263881300_bvag112-B27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1530\/EJE-14-0978","article-title":"Determining clinical and biological indicators for health outcomes in adult patients with childhood onset of congenital adrenal hyperplasia","volume":"173","author":"Bachelot","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2026070710263881300_bvag112-B28","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.fertnstert.2017.08.013","article-title":"Fertility outcome and information on fertility issues in individuals with different forms of disorders of sex development: findings from the dsd-LIFE study","volume":"108","author":"S\u0142owikowska-Hilczer","year":"2017","journal-title":"Fertil Steril"},{"issue":"12","key":"2026070710263881300_bvag112-B29","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1210\/jc.2012-2102","article-title":"Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia","volume":"97","author":"Finkielstain","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026070710263881300_bvag112-B30","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1007\/s12020-023-03330-w","article-title":"Long-term cardiometabolic morbidity in young adults with classic 21-hydroxylase deficiency congenital adrenal hyperplasia","volume":"80","author":"Righi","year":"2023","journal-title":"Endocrine"},{"issue":"3","key":"2026070710263881300_bvag112-B31","doi-asserted-by":"crossref","first-page":"e1175","DOI":"10.1210\/clinem\/dgad624","article-title":"Increased prevalence of accidents and injuries in congenital adrenal hyperplasia: a population-based cohort study","volume":"109","author":"Falhammar","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2026070710263881300_bvag112-B32","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1210\/jc.2016-2221","article-title":"Exploring inpatient hospitalizations and morbidity in patients with adrenal insufficiency","volume":"101","author":"Stewart","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026070710263881300_bvag112-B33","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1210\/clinem\/dgz006","article-title":"Increased infection risk in Addison\u2019s disease and congenital adrenal hyperplasia","volume":"105","author":"Tresoldi","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026070710263881300_bvag112-B34","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1210\/jc.2018-01862","article-title":"Cardiovascular and metabolic outcomes in congenital adrenal hyperplasia: a systematic review and meta-analysis","volume":"103","author":"Tamhane","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2026070710263881300_bvag112-B35","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1007\/s40618-023-02091-7","article-title":"Glucocorticoids and cognitive function: a walkthrough in endogenous and exogenous alterations","volume":"46","author":"De Alcubierre","year":"2023","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"2026070710263881300_bvag112-B36","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"11","key":"2026070710263881300_bvag112-B37","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"issue":"1","key":"2026070710263881300_bvag112-B38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000521288","article-title":"Charlson comorbidity index: a critical review of clinimetric properties","volume":"91","author":"Charlson","year":"2022","journal-title":"Psychother Psychosom"},{"issue":"7","key":"2026070710263881300_bvag112-B39","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/oem.2006.026716","article-title":"A 12 year prospective study of circulatory disease among Danish shift workers","volume":"63","author":"T\u00fcchsen","year":"2006","journal-title":"Occup Environ Med"},{"issue":"12","key":"2026070710263881300_bvag112-B40","article-title":"Polycystic ovary syndrome among female adolescents with congenital adrenal hyperplasia","volume":"13","author":"Abdelhamed","year":"2021","journal-title":"Cureus"},{"issue":"1","key":"2026070710263881300_bvag112-B41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/17446651.2025.2450423","article-title":"Glucocorticoid therapy in classic congenital adrenal hyperplasia: traditional and new treatment paradigms","volume":"20","author":"Bancos","year":"2025","journal-title":"Expert Rev Endocrinol Metab"},{"key":"2026070710263881300_bvag112-B42","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.2147\/CLEP.S269400","article-title":"Impact of the transition from ICD-9-CM to ICD-10-CM on the identification of pregnancy episodes in US health insurance claims data","volume":"12","author":"Sarayani","year":"2020","journal-title":"Clin Epidemiol"},{"issue":"11","key":"2026070710263881300_bvag112-B43","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s40264-021-01113-8","article-title":"Validating claims-based algorithms determining pregnancy outcomes and gestational age using a linked claims-electronic medical record database","volume":"44","author":"Moll","year":"2021","journal-title":"Drug Saf"},{"issue":"2","key":"2026070710263881300_bvag112-B44","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s40264-022-01261-5","article-title":"Development and validation of ICD-10-CM-based algorithms for date of last menstrual period, pregnancy outcomes, and infant outcomes","volume":"46","author":"Chomistek","year":"2023","journal-title":"Drug Saf"},{"issue":"4","key":"2026070710263881300_bvag112-B45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0284893","article-title":"Identification of pregnancies and their outcomes in healthcare claims data, 2008-2019: an algorithm","volume":"18","author":"Ailes","year":"2023","journal-title":"PLoS One"},{"issue":"7","key":"2026070710263881300_bvag112-B46","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1007\/s10067-018-4086-2","article-title":"Evaluation of the comorbidity burden in patients with ankylosing spondylitis using a large US administrative claims data set","volume":"37","author":"Walsh","year":"2018","journal-title":"Clin Rheumatol"},{"issue":"1","key":"2026070710263881300_bvag112-B47","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13075-023-03086-8","article-title":"Comorbidity in incident osteoarthritis cases and matched controls using electronic health record data","volume":"25","author":"Kamps","year":"2023","journal-title":"Arthritis Res Ther"},{"issue":"2 Part B","key":"2026070710263881300_bvag112-B48","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.cjco.2023.12.010","article-title":"Increased prevalence of adverse health outcomes across the lifespan in those affected by polycystic ovary syndrome: a Canadian population cohort","volume":"6","author":"Vine","year":"2024","journal-title":"CJC Open"},{"key":"2026070710263881300_bvag112-B49","author":"American College of Rheumatology"},{"key":"2026070710263881300_bvag112-B50","author":"Endocrine Society"},{"issue":"1","key":"2026070710263881300_bvag112-B51","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1378\/chest.56.1.43","article-title":"Blood pressure and risk of coronary heart disease: the Framingham study","volume":"56","author":"Kannel","year":"1969","journal-title":"Dis Chest"},{"issue":"3","key":"2026070710263881300_bvag112-B52","doi-asserted-by":"crossref","first-page":"e1133","DOI":"10.1210\/clinem\/dgad628","article-title":"Predictors of cardiovascular morbidities in adults with 21-hydroxylase deficiency congenital adrenal hyperplasia","volume":"109","author":"Charoensri","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026070710263881300_bvag112-B53","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11154-022-09770-5","article-title":"The management of congenital adrenal hyperplasia during preconception, pregnancy, and postpartum","volume":"24","author":"Maher","year":"2023","journal-title":"Rev Endocr Metab Disord"},{"issue":"2","key":"2026070710263881300_bvag112-B54","doi-asserted-by":"crossref","first-page":"e957","DOI":"10.1210\/clinem\/dgaa801","article-title":"Reproductive and perinatal outcomes in women with congenital adrenal hyperplasia: a population-based cohort study","volume":"106","author":"Hirschberg","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026070710263881300_bvag112-B55","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.rbmo.2020.08.036","article-title":"Pregnancy, delivery and neonatal outcomes among women with congenital adrenal hyperplasia: a study of a large US database","volume":"41","author":"Badeghiesh","year":"2020","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"2026070710263881300_bvag112-B56","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1530\/EJE-21-1109","article-title":"Health status of children and young persons with congenital adrenal hyperplasia in the UK (CAH-UK): a cross-sectional multi-centre study","volume":"187","author":"Bacila","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026070710263881300_bvag112-B57","first-page":"156","article-title":"Glucocorticoid dose and type are associated with depression scores in youth with classical congenital adrenal hyperplasia","volume":"18","author":"Liang","year":"2025","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"2026070710263881300_bvag112-B58","volume-title":"CRENESSITY\u2122 (Crinecerfont) Capsules and CRENESSITY\u2122 (Crinecerfont) Oral Solution Full Prescribing Information","author":"Neurocrine Biosciences, Inc","year":"2024"},{"issue":"6","key":"2026070710263881300_bvag112-B59","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1056\/NEJMoa2404656","article-title":"Phase 3 trial of crinecerfont in adult congenital adrenal hyperplasia","volume":"391","author":"Auchus","year":"2024","journal-title":"N Engl J Med"},{"issue":"4","key":"2026070710263881300_bvag112-B60","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1210\/er.2018-00258","article-title":"Testicular adrenal rest tumors: current insights on prevalence, characteristics, origin, and treatment","volume":"40","author":"Engels","year":"2019","journal-title":"Endocr Rev"},{"issue":"1","key":"2026070710263881300_bvag112-B61","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jpurol.2023.10.005","article-title":"Testicular adrenal rest tumors \u2013 epidemiology, diagnosis and treatment","volume":"20","author":"Eyer de Jesus","year":"2024","journal-title":"J Pediatr Urol"},{"key":"2026070710263881300_bvag112-B62","doi-asserted-by":"crossref","DOI":"10.1186\/1687-9856-2009-624823","article-title":"Testicular adrenal rest tumours in congenital adrenal hyperplasia","volume":"2009","author":"Claahsen-van der Grinten","year":"2009","journal-title":"Int J Pediatr Endocrinol"},{"issue":"5","key":"2026070710263881300_bvag112-B63","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1159\/000529211","article-title":"Patient and parent perspectives on testicular adrenal rest tumors in congenital adrenal hyperplasia","volume":"96","author":"Nebesio","year":"2023","journal-title":"Horm Res Paediatr"},{"issue":"6","key":"2026070710263881300_bvag112-B64","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/pch\/13.6.507","article-title":"Case 1: Severe acne - not just skin deep","volume":"13","author":"Savlov","year":"2008","journal-title":"Paediatr Child Health"},{"issue":"Suppl 1","key":"2026070710263881300_bvag112-B65","first-page":"3","article-title":"Clinical, biochemical and molecular characteristics of congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"17","author":"Odabasi Gunes","year":"2024","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"5","key":"2026070710263881300_bvag112-B66","first-page":"1190","article-title":"Congenital adrenal hyperplasia: not really a zebra","volume":"59","author":"Deaton","year":"1999","journal-title":"Am Fam Physician"},{"issue":"3","key":"2026070710263881300_bvag112-B67","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-045343","article-title":"Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic review","volume":"11","author":"Moynihan","year":"2021","journal-title":"BMJ Open"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvag112\/68282103\/bvag112.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/10\/7\/bvag112\/68282103\/bvag112.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/10\/7\/bvag112\/68282103\/bvag112.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T14:26:48Z","timestamp":1783434408000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvag112\/8677787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":67,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,6,3]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvag112","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,5,13]]},"article-number":"bvag112"}}